Employees & Salary
3
Within the healthcare industry it would be advantageous to go to an area that has the demand for professionals in the industry, but the area is not oversaturated by those in the profession. I worked in the healthcare industry in New Jersey / New York area, and I would always hear it was difficult to get a job in the induistry in the area due to the amount of competition. This is something that would have to be considered.
3/62
Economic Activity Level
4
Regions such as New York and California have a higher number of total enterprises, however they are operating at a tremendous loss.
4/62
Profitability Distribution by Industry
6
This shows the profitability of healthcare vs industrials. The healthcare industry receives more profit. If going for the money, the healthcare industry would be the choice to make. This image shows the Industrials industry with very low numbers. The following slide shows the healthcare industry.
6/62
Enterprise Ranking - Gross Profit
9
These are the top 10 ranking organizations based on gross profit. These are organizations within the industry that are not operating at a loss.
9/62
Return on Assets vs. Liability Asset Ratio
10
Many organizations experience a low asset liability ratio. They have few liabilities based on their current assets.
10/62
Benchmark by Industry - Efficiency
11
Financially, the healthcare industry is difficult to determine when it is doing well or not. Because of the nature of receiving payments from patients and inventory being turned quickly because of it being a necessity for survival it doesn't necessarily mean an organization, or the industry is thriving as well as it is being perceived.
11/62
Enterprise Breakdown - Revenue
12
Comparing the overall healthcare industry to Pfizer and J&J, both organizations that are leaders within the industry, it can be noted that Net Income is higher than the average .
12/62
Enterprise Distribution
16
California and Massachusetts
16/62
Typical Firm Performance by Region - Profit Distribution
17
Areas that experience the largest profit distribution in the industry are Indiana, Delaware, and Wisconsin
17/62
Concentration and Competition Intensity - Total Revenue
18
Healthcare equipment and services
18/62
Industrial Trend - Industry Total Size
19
China is not as profitable and does not experience as much revenue within the industry. Even during Covid when the US experience a major drop in net income, the US industry outperformed China's industry.
19/62
Industrial Trend - Efficiency
21
Financially, The US is performing better in the industry from a supply chain perspective. Inventory is not being held as long and the cash conversion cycle is higher showing it takes them lower to turn their assets into cash. US has lower Overall, the typical company performance trend is going down for both the US and China
21/62
Industrial Trend - Financial Health
22
The US and China have similar Operating cash and a higher liability asset ratio. Their liability asset ratio shows that the US has a high liabilities in comparison to their assets which can be an issue in the profitability of the
22/62
Industrial Comparison - Profitability
23
When compared to the Health Care Equipment & Services Industry, the Pharmaceuticals industry
23/62
Industrial Comparison - Growth
24
The pharmaceutical industry has a higher potential for growth in their revenue and income.
24/62
Industrial Comparison - Efficiency
25
Pharmecueticals has a lower inventory turnover
25/62
Revenue vs. Cost
26
J&J and Pfizer are experiencing continuous increase in revenue despite an increase in cost. The leading companies in the industry has less costs than those in the Equipment industry.
26/62
Return on Assets vs. Liability Asset Ratio
30
Nunz has the worst performance in ROA but good financial performance. Many of the other organizations within the industry experience a healthy ROA with good financial performance.
30/62
Industrial Trend - Industry Total Size
33
The pharma and biotechnology industry has less profitable enterprises within the industry, however the industry continuously experiences higher operating income. An exception was during Covid. This could be a factor of increased healthcare concerns and hospitalizations with the rapid growth of the virus. Despite this, the Pharma sector has been showing growth post-Covid and reclaiming its competitive position within the healthcare industry. This shows that the sector has been doing well due to long-term strategic operations and not short-term economic disease.
33/62
Concentration and Competition Intensity - Total Revenue
35
Over the years there have been 5 industries that have clearly saturated the industry and claimed most of the revenue within the industry. This graph also shows that over the years, there have been more organizations that have been receiving revenue and this is shown through the addition of data on the graph. This could be due to the advancements in technology and economic building of entrepreneurship that has lead to the growth within the industry. Also, factors similar to Covid, the Flu, Cancer and other major health concerns contributes to the growth of the industry.
35/62
Concentration and Competition Intensity - Four-firm Concentration Ratio
37
Within the healthcare industry, Healthcare Equipment and services is more concentrated and more competitive than the pharma and biotechnology fields. Health care services is an area that is comprised of more subcategories and everyday essentials of life. This analysis is reasonable as it reflects a higher concentration based on higher usage.
37/62
Supply Chain Mapping - Net Margin (Global 2021)
41
This shows that globally Switzerland has the highest net margin within the industry globally.
41/62
Profit vs. Total Assets - Operating Income
45
When it comes to operating income in comparison to total assets between the US and China, the US has shown results of higher operating income being affiliated with higher total assets. There has been a steady growth trend in the US while China reflects almost a linear flat trend with slight increase. This could be due to the differing healthcare industries.
45/62
Total Assets Breakdown (Post-Covid) 2021
62
Over the three years (pre-covid, Covid, and Post-Covid), Johnson and Johnson maintained its competitive position within the industry, however the organization lacked long-term investments in comparison to its competitors. The organization also had a higher amount of inventory than the industry standard. Despite this, the organization succeeded in maintaining its competitive advantage. In comparison, Pfizer had an extremely low amount of cash on hand however reflects almost double of the industry standard in long-term investments. This shows that the organization's successes could be in part to their strategic investments and not necessarily the cash flows for that year. This was maintained through the three year period.
62/62